Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PREP | P48147 | 5/20 | 0.58 |
| ▸ | ACE | P12821 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | FKBP1A | P62942 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22811402 | 0.88 | PREP (0.54) | PREPACEALDH1A1CYP3A4 | |
| SCHEMBL2084721 | 0.88 | PREP (0.54) | PREPACEALDH1A1CYP3A4 | |
| SCHEMBL11764594 | 0.87 | PREP (0.71) | PREPACEALDH1A1FKBP1AKMT2A | |
| SCHEMBL2228388 | 0.87 | PREP (0.71) | PREPACEALDH1A1FKBP1AKMT2A | |
| SCHEMBL10476852 | 0.85 | PREP (0.62) | PREPTSHRKMT2A | |
| SCHEMBL29591617 | 0.85 | OPRD1 (0.44) | PREPACEKMT2ACHRM2CHRM4 | |
| SCHEMBL11761001 | 0.84 | PREP (0.67) | PREPACEALDH1A1FKBP1AKMT2A | |
| SCHEMBL11760983 | 0.84 | PREP (0.67) | PREPACEALDH1A1FKBP1AKMT2A | |
| SCHEMBL13471059 | 0.84 | PREP (0.67) | PREPACEALDH1A1FKBP1AKMT2A | |
| SCHEMBL4244330 | 0.84 | PREP (0.66) | PREPACEALDH1A1FKBP1AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230037643-A1 | METHOD FOR PRODUCING PEPTIDE | OTSUKA CHEMICAL CO., LTD. (JP) | 2023-02-09 | — | — | US | disclosed |
| EP-4095147-A1 | METHOD FOR PRODUCING PEPTIDE | Otsuka Chemical Co., Ltd. (JP) | 2022-11-30 | — | — | EP | disclosed |
| CN-114901670-A | Method for producing peptide | 大塚化学株式会社 | 2022-08-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230037643-A1 | METHOD FOR PRODUCING PEPTIDE | VIP, NPPA, ANPEP | PREP 15/4885ACE 1132/4885ALDH1A1 4701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.